Why heart disease mortality is low in France: the time lag explanation
about
Omega 6 fatty acids for the primary prevention of cardiovascular diseaseOmega 6 fatty acids for the primary prevention of cardiovascular diseaseIncreased consumption of fruit and vegetables for the primary prevention of cardiovascular diseasesIncreased consumption of fruit and vegetables for the primary prevention of cardiovascular diseasesWhy mortality from heart disease is low in France. Rates of coronary events are similar in France and Southern EuropeDeteriorating health satisfaction among immigrants from Eastern Europe to GermanyAll-cause and cardiovascular mortality among ethnic German immigrants from the Former Soviet Union: a cohort studyIs wine good for your heart? A critical reviewAlcohol-free red wine prevents arterial thrombosis in dietary-induced hypercholesterolemic rats: experimental support for the 'French paradox'Engineering vascularized tissues using natural and synthetic small moleculesImpact of primary health care on mortality from heart and cerebrovascular diseases in Brazil: a nationwide analysis of longitudinal dataRisk factor thresholds. Threshold is 37 000 pounds sterling per QALYModelling the decline in coronary heart disease deaths in England and Wales, 1981-2000: comparing contributions from primary prevention and secondary preventionThe fetal origins of disease hypothesis: public health implications for the Asia-Pacific region.Social distribution of cardiovascular disease risk factors: change among men in England 1984-1993Life course epidemiology.Preclinical coronary atherosclerosis in a population with low incidence of myocardial infarction: cross sectional autopsy study.Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitorLipids and stroke: the opportunity of lipid-lowering treatment.Homogeneity in the relationship of serum cholesterol to coronary deaths across different cultures: 40-year follow-up of the Seven Countries StudyEstimating the cardiovascular mortality burden attributable to the European Common Agricultural Policy on dietary saturated fats.Wine polyphenols and promotion of cardiac health.Effects of wine, alcohol and polyphenols on cardiovascular disease risk factors: evidences from human studies.Chemistry and Biology of Resveratrol-Derived Natural ProductsTime travel with Oliver Twist--towards an explanation foa a paradoxically low mortality among recent immigrants.Differences in mortality between groups of older migrants and older non-migrants in Belgium, 2001-09.Protective effects of red wine polyphenolic compounds on the cardiovascular system.Dietary patterns among children aged 6-7 y in four Spanish cities with widely differing cardiovascular mortality.Attribution of time lag theory to explain French paradox.Why heart disease mortality is low in France. Miscoding may explain Japan's low mortality from coronary heart disease.Paying for the NHS. First decide how much we are willing to pay, then think about how to collect it.Does the Mediterranean paradox extend to abdominal aortic aneurysm?Cardioprotection with resveratrol pretreatment: improved beneficial effects over standard treatment in rat hearts after global ischemia.Flavonoids inhibit platelet function through binding to the thromboxane A2 receptor.Public Health Spending and Medicare Resource Use: A Longitudinal Analysis of U.S. Communities.Effects of resveratrol on number and activity of endothelial progenitor cells from human peripheral blood.Editorial: One more roast leg of mutton? A novel view of dietary fat
P2860
Q24187758-CF9F5355-EC2A-4CE1-A6F5-1BD80F364C53Q24194879-01C1529A-26B0-469E-8A08-2C627938BD9DQ24198889-78D5B422-CD47-4A31-86FF-306F68EA18DBQ24202276-B83E2D82-0520-4A9D-8B32-6382FEA23603Q24524570-F99A2F87-DBE0-48F6-A6A7-5F23821B0DABQ24798289-123CB6D3-FD00-4FFD-A1EA-4FBCED04949AQ25257406-47289079-F832-45EF-BD0F-3C003CC301B6Q28354008-6B96C91F-1AA7-4858-81F6-2ADB463BDC77Q28568870-2184AC35-1060-4FA9-AB9C-78A1B0A22677Q30439954-E69120A0-00BD-4409-BF30-5E54D0A7AC1AQ30835138-B77C504A-4AD5-4CA6-B301-1A9AF7DBE1E4Q33812841-968E0F5E-33FF-4BBB-B215-907A076E002EQ33998019-17E6843D-7AC1-4ED5-9EA5-88DB878AF8C4Q35070584-E37CCF4F-3243-4353-9666-8DB587982C94Q35400359-07E628CD-74B2-48AF-948F-6CD3657188E2Q35409893-17BA77E8-5408-435F-9382-3A52DD86D5A5Q35926674-EA1909A0-9D2C-4A8D-B45B-3E0DF8A4ACAEQ36086859-03355CFB-626D-47C2-9A70-C03B29FCD6F0Q36331015-34ADFB7C-CD14-4B47-B58F-F31455FB9C9DQ37095862-C4BEA547-9300-423E-A673-37EDEBC0E290Q37108949-838462C3-0EEB-4FB9-80E6-4715056B98C5Q37350069-9DBA89FB-3B0B-4F80-9182-0759CC2C5DB6Q38081384-346B5460-9E33-4269-B45C-DFD326C34BE5Q38401947-CEBA9842-B8B3-44AA-9C1F-4DFE44D79D94Q39387695-879FB632-44AB-4E1E-92DB-CC091B5E7B11Q39677142-63D020E3-5C3B-4043-B7D5-E64FFF463539Q40169597-16A36174-C053-4782-A116-A07BCFC210E5Q40658619-52BFE331-1F45-4A4F-8620-CC85062B29F3Q42135144-8D8FD1BE-340B-4E42-84CF-43ACD909443EQ42259149-B57C79F3-3805-42D2-86A6-7F1924FF7E18Q42765897-F8D9C9E2-CFE5-4ED7-92EB-EAA0B31BDACEQ43786781-E994B081-502C-47C6-A733-41C300DD220AQ45156261-23489540-E9F2-4C7C-88AF-E2AD161D0307Q45237834-AD3EF511-E832-4985-B125-8B0303DCA1C8Q47610258-CDA76D2D-4D76-4475-98F5-903CE9B87FEDQ53526716-3D277818-B14E-4E26-874D-BD084A479680Q56836516-7B41669C-3FF9-466B-AE9A-F0FD1A398701
P2860
Why heart disease mortality is low in France: the time lag explanation
description
1999 nî lūn-bûn
@nan
1999 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի մայիսին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Why heart disease mortality is low in France: the time lag explanation
@ast
Why heart disease mortality is low in France: the time lag explanation
@en
type
label
Why heart disease mortality is low in France: the time lag explanation
@ast
Why heart disease mortality is low in France: the time lag explanation
@en
prefLabel
Why heart disease mortality is low in France: the time lag explanation
@ast
Why heart disease mortality is low in France: the time lag explanation
@en
P2860
P1433
P1476
Why heart disease mortality is low in France: the time lag explanation
@en
P2860
P304
P356
10.1136/BMJ.318.7196.1471
P407
P577
1999-05-01T00:00:00Z